Aetna is hitting back at allegations that its decision to withdraw from a number of Affordable Care Act state exchanges was politically motivated.

The insurer's move to leave all but a few state marketplaces was just business, so says CEO Mark Bertolini in a letter to a group of senators Tuesday.

His letter was a response to one authored by five Democrats, including Elizabeth Warren and former presidential candidate Bernie Sanders, who accused the company of abandoning its Obamacare customers as retaliation for the Obama administration's attempt to block its merger with Humana.

Recommended For You

Bertolini called their allegations baseless.

"In this highly politicized environment, it may be tempting to make such accusations rather than examine the forces creating an unsustainable public exchange marketplace, but they do not move us toward fixing the problem," he writes.

Aetna's argument appears to have convinced at least one Democrat in its home state of Connecticut. Sen. Chris Murphy told the Hartford Courant that there was "simply no basis" to believe Aetna's business decision was political. Murphy might be giving cover to the insurer in the hopes that it will keep its headquarters in Hartford, an otherwise economically challenged city that some have suggested it might abandon if it goes through with its merger.

Aetna is certainly not alone in expressing concerns about the financial viability of the ACA exchanges. UnitedHealth, the nation's largest insurer, announced earlier this year that it would abandon most of its exchange business, citing an inability to make a profit.

But what struck observers as fishy about similar announcements from Aetna and Humana in August was that they came right after the U.S. Department of Justice announced that it would challenge their proposed merger in court. In addition, both companies had expressed optimism about their exchange business only months earlier, even indicating that they would expand in the coming year. 

NOT FOR REPRINT

© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.